Roche Licenses Melting Curve, SYBR Green Tech to Takara Bio for Use in Real-Time PCR Instruments and Kits | GenomeWeb

Roche Diagnostics said today that it has signed a license agreement with Takara Bio of Shiga, Japan, that gives Takara the right to use melting curve analysis technology and SYBR Green techniques in kits and instruments for real-time PCR.

Specifically, the agreement gives Takara a non-exclusive license for the use of the technology with instruments in Japan, and for worldwide use in kits, in the field of research applications.

Financial terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.